Fonte: Critical Care - The official journal of the Critical Care Forum. Nome do evento: Second International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, L. et al. Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity. Critical Care - The official journal of the Critical Care Forum. Belgium: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 06 out. 2024. , 2003APA
Fernandes, L., Martinez, L. L., Carvalho, M. H. C. de, Muscará, M. N., Fortes, Z. B., & Teixeira, S. A. (2003). Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity. Critical Care - The official journal of the Critical Care Forum. Belgium: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Fernandes L, Martinez LL, Carvalho MHC de, Muscará MN, Fortes ZB, Teixeira SA. Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity. Critical Care - The official journal of the Critical Care Forum. 2003 ; 7 S58.[citado 2024 out. 06 ]Vancouver
Fernandes L, Martinez LL, Carvalho MHC de, Muscará MN, Fortes ZB, Teixeira SA. Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity. Critical Care - The official journal of the Critical Care Forum. 2003 ; 7 S58.[citado 2024 out. 06 ]